Bone marrow and stem cell transplantation is used to treat diseases, such as acute and chronic leukemia; aplastic anemia; preleukemia and marrow failure states; non-Hodgkin's lymphoma; Hodgkin's disease; multiple myeloma; solid tumors, including breast cancer, ovarian cancer and germ cell tumors; and rare inherited or acquired disorders, such as thalassemia, amyloidosis and autoimmune diseases.
The Washington University Bone Marrow and Stem Cell Transplant Program is one of the 10th largest in the world.
The program has performed unrelated donor transplants since 1991 and outpatient autologous stem cell transplants since 1994. It also has been an active member of the National Marrow Donor Program, the International Bone Marrow Transplant Registry, and the Cancer and Leukemia Group B (CALGB) Transplant Consortium.
Supported by the Siteman Cancer Center, the bone marrow and stem cell transplantation program provides a full range of supportive services.
Since 1982, more than 2,220 patients have received bone marrow or stem cell transplants at Barnes-Jewish Hospital.
An initial patient consultation includes a complete review of all medical records, as well as a physical exam. At this time, the transplant physicians will determine if the patient meets all eligibility requirements and, if so, which type of transplant is optimal.
Besides the clinical and research physicians in the section of bone-marrow transplantation, a whole BMT team of specialists in pheresis (stem cell collection and transfusion medicine), bone marrow transplant and oncology nursing, pharmacy, nutrition, physical therapy, social work, pastoral care, data management and financial planning treat patients with skill, care and understanding.
Post treatment accommodations are available at several locations in the area.
Douglas R. Adkins, M.D.
John F. DiPersio, M.D., Ph.D., Division Chief (pictured above)
Michael Tomasson , M.D.
Ravi Vij, M.D.